A vaccinia virus renaissance<subtitle>New vaccine and immunotherapeutic uses after smallpox eradication</subtitle>
In 1796, Edward Jenner introduced the concept of vaccination with cowpox virus, an Orthopoxvirus within the family Poxviridae that elicits cross protective immunity against related orthopoxviruses, including smallpox virus (variola virus). Over time, vaccinia virus (VACV) replaced cowpox virus as th...
Saved in:
| Main Authors: | Paulo H. Verardi, Allison Titong, Caitlin J. Hagen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2012-07-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.4161/hv.21080 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of means and principles of smallpox vaccination
by: S. V. Borisevich, et al.
Published: (2020-06-01) -
Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models
by: Kyle G Potts, et al.
Published: (2017-03-01) -
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
by: Richard N. Greenberg, et al.
Published: (2024-12-01) -
Correlations between Humoral Immunity, Vaccination Period and Demographic Characteristics of First Immunized Smallpox Vaccine Recipients
by: O. S. Ermilova, et al.
Published: (2020-03-01) -
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
by: Wenyi Yan, et al.
Published: (2025-04-01)